— Know what they know.
Not Investment Advice

INIS OTC

Radnostix, Inc.
1W: +3.3% 1M: +14.6% 3M: -6.7% YTD: +5.0% 1Y: +5.0% 3Y: +37.5% 5Y: -42.7%
$0.06
-0.00 (-3.08%)
 
Weekly Expected Move ±11.4%
$0 $0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 58 · $33.3M mcap · 107M float · 0.041% daily turnover · Short 44% of daily vol

Income Trends

Revenue
$14M +13.3% ▲
5Y CAGR: +9.2%
Gross Profit
$9M +17.2% ▲
5Y CAGR: +13.1%
Operating Income
$7K +100.9% ▲
Net Income
$9K +101.0% ▲
EPS (Diluted)
$0.00 +100.0% ▲
EBITDA
$804K +593.0% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$9M$10M$11M$12M$14M
YoY Growth+4.6%+3.2%+15.7%+9.7%+13.3%
Cost of Revenue$4M$4M$5M$5M$5M
Gross Profit$5M$6M$6M$7M$9M
Gross Margin58.3%59.4%56.3%60.2%62.2%
R&D Expenses$219K$272K$534K$577K$611K
SG&A Expenses$6M$6M$7M$8M$4M
Operating Expenses$6M$6M$7M$8M$9M
Operating Income$3M$3K$917K-$776K$7K
Operating Margin34.4%0.0%8.2%-6.3%0.0%
Interest Expense$782K$792K$614K$332K$329K
Income Before Tax$2M-$789K$303K-$869K$9K
Tax Expense$0$0$0$0$0
Net Income-$2M-$2M-$311K-$869K$9K
Net Margin-23.7%-24.6%-2.8%-7.1%0.1%
EPS (Diluted)$-0.01$-0.01$-0.00$-0.00$0.00
EBITDA$4M$631K$1M-$163K$804K
Shares Outstanding431M478M511M518M522M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms